Net Income (Loss) Attributable to Parent in USD of ESSA Pharma Inc. from 2019 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
ESSA Pharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2019 to Q2 2025.
- ESSA Pharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2025 was -$4M, a 44.7% increase year-over-year.
- ESSA Pharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Jun 2025 was -$25.3M, a 8.69% increase year-over-year.
- ESSA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$28.5M, a 7.38% decline from 2023.
- ESSA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$26.6M, a 24.3% increase from 2022.
- ESSA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$35.1M, a 4.63% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)